All News

Filter News

Found 2,297 articles

Avacta Group plc Pre-Close Trading Update

1/25/2016
Akcea Therapeutics Appoints Louis St. L. O'Dea As Chief Medical Officer

1/19/2016
Booming Moderna Eyes Six Human Trials in 2016, Inks Deals with AstraZeneca PLC, Merck & Co. and Signed Huge Lease in Cambridge for R&D Growth

1/12/2016
Moderna Announces Transition To A Clinical Stage Company, Provides Business Update And Outlines 2016 Strategic Priorities

1/12/2016
Moderna, Through Valera, Its Infectious Disease Venture, Announces Initial Grant Of Up To $20 Million To Advance mRNA-Based Antibody Combination To Help Prevent HIV Infection

1/12/2016
Moderna Licenses New Vaccine Candidates Against A New Viral Target To Merck & Co.

1/11/2016
AstraZeneca PLC And Moderna Announce New Collaboration To Co-Develop And Co-Commercialize Immuno-Oncology mRNA Therapeutics

1/11/2016
Moderna And PPD Announce Strategic Collaboration To Support Clinical Development Of Novel mRNATherapeutics

1/8/2016
Moderna To Present At 2016 J.P. Morgan Healthcare Conference

1/4/2016
Evelo Expands To New HQ In Cambridge

12/17/2015
Dr. Elizabeth Nabel Joins Moderna’s Board Of Directors

12/15/2015
PureTech Names Scientific Advisory Board And Expands Senior Team

11/30/2015
Former Biogen Exec Doug Williams to Head Startup Codiak BioSciences

11/18/2015
Exclusive: Evelo CEO Talks Company Launch, $35 Million Funding Round

11/4/2015
Arcturus Therapeutics Stands to Collect Up to $1.66 Billion from Rare Disease Pact with Ultragenyx

10/30/2015
Avacta Group plc Release: Preliminary Results for the Year Ended 31 July 2015

10/26/2015
Engineered mRNA Company Moderna Launches 4th Spinoff, Caperna

10/22/2015
Former Genzyme CEO Henri Termeer Leads $10 Million Series B for Autoimmune Company Artax Biopharma

9/22/2015
Avacta Group plc Appoints Dr Mike Owen As Non-executive Director

9/17/2015
Merck & Co., GlaxoSmithKline and Others Invest $55 Million in RaNA Therapeutics and Its Innovative RNA Technology

7/23/2015